All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
Lantern Pharma Inc., a Dallas-based cancer medicines developer using a machine learning platform to accelerate its work, is raising $60 million through a public offering priced at $14 per share (NASDAQ:LTRN).